Patrick J. McEnany, President and CEO at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 52,302 shares at $13.23 ($692K) on 2023-05-15, disclosed to the SEC on 2023-05-17.
Open-market sale of $692k CPRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.23 | 26,151 | $346K | 50.0% |
| 2 | $13.23 | 26,151 | $346K | 50.0% |
| Total | $13.23 avg | 52,302 | $692K | 100% |
| Filing → |
| CPRX | SELL | 2024-11-15 | $4.1M | — | Filing → |
| CPRX | SELL | 2024-11-13 | $13.1M | — | Filing → |
| CPRX | SELL | 2022-11-22 | $7.8M | — | Filing → |